US FDA Approves Sun Pharma's ILUMYA for Psoriatic Arthritis
The US FDA has approved Sun Pharma’s ILUMYA in the US for adults with active psoriatic arthritis, expanding its use beyond plaque psoriasis.
Psoriatic Arthritis Drug | 30/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy